Home > Healthcare > Medical Devices > Implantable Devices > Annuloplasty System Market
Annuloplasty System Market size was valued at USD 473.9 million in 2023 and is anticipated to witness growth at a CAGR of 8.2% between 2024 and 2032, driven by the rising burden of cardiovascular diseases coupled with the surging demand for minimally invasive procedures.
Cardiovascular diseases (CVDs), including conditions such as mitral valve regurgitation and tricuspid valve insufficiency are on the rise globally due to factors such as aging populations, sedentary lifestyles, unhealthy dietary habits, and increasing prevalence of risk factors like hypertension and diabetes. For instance, according to the American College of Cardiology, global death counts due to CVD increased from 12.4 million in 1990 to 19.8 million in 2022. As the incidence of these conditions continues to grow, there is an increasing demand for interventions such as annuloplasty systems to address valvular defects and restore cardiac function.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Annuloplasty System Market Size in 2023: | USD 473.9 Million |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 8.2% |
2032 Value Projection: | USD 967.8 Million |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 110 |
Tables, Charts & Figures: | 150 |
Segments covered: | Rigidity, Application, Shape, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Moreover, patients are increasingly opting for minimally invasive procedures over traditional open-heart surgeries due to several advantages, including reduced postoperative pain, shorter hospital stays, faster recovery times, and improved cosmetic outcomes. Consequently, annuloplasty systems that support minimally invasive approaches, such as robotic-assisted surgery or percutaneous interventions, are favored by patients seeking less invasive treatment options for valvular disorders.
An annuloplasty system comprises annuloplasty rings and bands, which are medical devices utilized in cardiac surgery to repair or reconstruct the fibrous ring surrounding heart valves, particularly the mitral and tricuspid valves. These structural heart devices are engineered to restore the natural shape, size, and function of the valve annulus, thereby improving valve leaflet coaptation, reducing valve regurgitation, and restoring proper valve function.